SOURCES SOUGHT
66 -- Installation and Maintenance of Illumina HiSeq 2500 Sequencing System
- Notice Date
- 5/7/2014
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIDA-SSSA-2014-208
- Archive Date
- 5/31/2014
- Point of Contact
- Rodney E. Brooks, Phone: 3014020751
- E-Mail Address
-
rodney.brooks@nih.gov
(rodney.brooks@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support Simplified Acquisitions, 9000 Rockville Pike, Bldg. 31, Room 1B57 Bethesda, MD 20892, UNITED STATES Introduction: This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources, (2) whether they are small businesses; HUBZone small businesses, service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. Background Information: National Institutes of Health has purchased a number of Illumina's Sequencing Systems which have a proven platform for genetic analysis and functional genomics. The instrument's parallel sequencing technology leverages clonal cluster formation and proprietary reversible terminator chemistry to give it the speed and reduce the cost of large-scale sequencing to generate billions of bases of high-quality DNA sequence per run. The Illumina Sequencing technology also provides an easy-to-use protocol that does not require emulsion Polymerase Chain Reaction (PCR) which allows for a self-contained system that minimizes handling errors and contamination concerns, eliminating the need for robotics or clean rooms. Over the last several years the National Institutes of Health purchased Illumina manufactured instruments such as, twenty-seven (27) Genome Analyzers, twelve (12) BeadArray TM Systems, and seven (7) iScan Systems for use in its research facilities. Currently, NIH spends approximately 2 million dollars on reagents and consumables, and once all the instruments are fully operational, the NIH expects these figures to increase to approximately 5 million dollars per year. Each of the Illumina systems requires the use of reagents and consumables to ensure efficient operation and the desired outcomes of the operating systems. Reagents are chemicals and enzymes used to perform an assay or research sequencing methodology. Consumables are Arrays, Custom Arrays, Custom Oligo Pools, Standard Oligo Pools, Flow Cells, and accessories, Sample Preparation Kits, Cluster Kits, Sequencing Kits and Reagent Kits which are also used in the sequencing process. All reagents and consumables must be compatible with, and optimally perform in the Illumina manufactured systems. Purpose and Objectives for the Procurement: The purpose of the requirement is to purchase of laboratory reagents and equipment for whole exome sequencing and genome-wide genotyping of families with Parkinson's disease, And for the installation and maintenance of the Illumina HiSeq 2500 Sequencing System. Contractor Requirements: The contractor shall provide: • HiSeq 2500 Sequencing System • Nextera Rapid caputure Expanded Exome Kit • TruSeq Dual Indexing Sequencing Primer Kit • HiSeq SBS Kit v4. • Hi Seq PE Cluster Kit v4. • Provide installation and maintenance of the Illumina HiSeq 2500 Sequencing System. • Provide written reports on installation and maintenance on the Illumina HiSeq 2500 Sequencing System The period of performance is 30 days after purchase order is issued. Capability Statement: Businesses that believe they possess the capabilities necessary to undertake this work should submit complete documentation of their capabilities to the Contract Specialist. The capabilities statement must specifically address each project requirement separately. Additionally, the capability statement should include 1) the total number of employees, 2) the professional qualifications of scientists, medical experts and technical personnel as it relates to the above outlined requirements, 3) a description of general and specific facilities and equipment available, including computer equipment and software, 4) an outline of pervious research projects that are similar to the project requirements in which the organization and proposed personnel have participated, and 5) any other information considered relevant to this program. The capability statement must not exceed 15 single sided or 7.5 double sided pages in length and using a 12-point font size minimum. Interested organizations are required to identify their size standards in accordance with the Small Business Administration. The government requests that no proprietary or confidential business data be submitted in a response to this notice. However, responses that indicate the information therein is proprietary will be properly safeguarded for Government use only. Capability statements must include the name and telephone number of a point of contact having authority and knowledge to discuss responses with Government representatives. Capability statements in response to this market survey that do not provide sufficient information for evaluation will be considered non-responsive. When submitting this information, please reference the solicitation notice number. All capability statements sent in response to this Sources Sought Notice must be submitted electronically (via email) to Rodney Brooks, Contract Specialist at rodney.brooks@nih.gov in MS Word within 7 calendar days of the date of this announcement. All responses must be received by the specified due date and time in order to be considered. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in the response. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After reviewed of the responses received, pre-solicitation and solicitation notices may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. The solicitation release date is pending. The Government intends to negotiate a fixed-price contract.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SSSA-2014-208/listing.html)
- Record
- SN03359157-W 20140509/140507234149-01e0e19409ada86ba68cfb9d3f406ad6 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |